162
1Zhejiang University Hospital Successfully Performs First Closed-Loop Spinal Nerve Interface Surgery, Bringing Hope to Paraplegic Patients
浙江大学医院成功实施首例闭环脊髓神经接口手术，为截瘫患者带来希望Zhejiang University School of Medicine's Second Affiliated Hospital successfully performed the first-ever closed-loop spinal nerve interface implant surgery in China, helping a 61-year-old paraplegic patient, Mr. Jin, regain the ability to walk autonomously.
浙江大学医学院附属第二医院成功进行了全国首例闭环脊髓神经接口植入手术，帮助61岁的截瘫患者金大叔重新实现自主行走。The surgery utilized self-developed neural interface products, including spinal cord stimulation electrodes, a wireless charging controller, and an electromyography signal acquisition device, forming a closed-loop system capable of precisely activating muscle groups.
这项手术采用了自主研发的神经接口产品，包括脊髓刺激电极、无线充电控制器和肌电信号采集装置，形成了闭环系统，能够精准激活肌肉群。Post-surgery, Mr. Jin was able to gradually walk again and significantly improved his quality of life.
术后，金大叔能够逐步恢复行走能力，并明显改善了生活质量。This technology brings hope to nearly 4 million spinal cord injury patients and marks a significant breakthrough in the field of spinal nerve recovery.
这项技术为近400万脊髓损伤患者带来了新的希望，标志着脊髓神经恢复领域的重要突破。The success of this surgery introduces a new direction for medical research and practice.
手术的成功为医学界带来了全新的研究方向和实践范式。
Huawei Releases Two New HarmonyOS Laptops, Marking a Breakthrough in Domestic Operating Systems
华为发布两款新型鸿蒙电脑，国产操作系统迎来突破Huawei officially launched two new HarmonyOS laptops in Chengdu: the Huawei MateBook Fold Extraordinary Master and Huawei MateBook Pro, both equipped with the latest HarmonyOS 5.
华为在成都正式发布了两款新型鸿蒙电脑，分别是华为MateBook Fold非凡大师和华为MateBook Pro，均搭载最新的HarmonyOS 5系统。The MateBook Fold starts at 23,999 yuan, and the MateBook Pro starts at 7,999 yuan, marking a significant breakthrough for domestic operating systems in the personal computer sector.
MateBook Fold的起售价为23999元，MateBook Pro的起售价为7999元，这标志着国产操作系统在个人电脑领域的实现了重要突破。The release not only strengthens the competitiveness of domestic operating systems but also demonstrates Huawei's ongoing efforts in technological innovation.
此次发布不仅提升了国产操作系统的市场竞争力，也展现了华为在技术创新方面的持续努力。With Huawei's technological advancements and product innovations, China's tech industry is gradually taking a more prominent position in the global market.
随着华为的技术进步和产品创新，中国的科技行业逐渐在全球市场上占据越来越重要的地位，迈向国际化。
Xiaomi Unveils 3nm Processor, Becoming the Fourth Company in the World to Do So
小米发布3nm处理器，成为全球第四家推出该技术的公司Xiaomi Group Chairman Lei Jun announced on Weibo that Xiaomi's new Xuanjie O1 mobile processor uses second-generation 3nm process technology, making Xiaomi the fourth company in the world to release a self-developed 3nm processor.
小米集团董事长雷军在微博上宣布，小米新推出的玄戒O1手机处理器采用第二代3nm工艺制程，成为全球第四家发布自主研发3nm处理器的公司。Lei Jun stated that the project has accumulated over 13.5 billion yuan in investment so far, with more than 2,500 researchers involved, and expects the research and development investment to exceed 6 billion yuan this year.
雷军表示，项目至今累计投入超过135亿元，研发团队人数已超过2500人，预计今年的研发投入将突破60亿元。This marks a significant breakthrough in Xiaomi's chip research and development design, demonstrating China's potential in technological innovation.
这标志着小米在芯片研发设计上的显著突破，证明了中国企业在技术创新方面的强大潜力。Despite these achievements, Lei Jun admitted that Xiaomi is still in the early stages of chip design, but this success lays a solid foundation for future development.
尽管如此，雷军也坦言，小米在芯片设计方面仍处于初步阶段，但这项成就为未来的发展奠定了坚实的基础。
Sihuan Pharmaceutical Signs Landmark Licensing Agreement with Pfizer for Innovative Antibody, Boosting International Market Presence
三生制药与辉瑞签署创新药物许可协议，推动中国药企国际化Sihuan Pharmaceutical has signed a major licensing agreement with Pfizer, granting exclusive rights for its self-developed PD-1/VEGF bispecific antibody "SSGJ-707" in markets outside of China.
三生制药与辉瑞签署了一项重要的许可协议，将其自研的PD-1/VEGF双特异性抗体“SSGJ-707”独家授权给辉瑞，覆盖全球市场（除中国）。Sihuan will receive an upfront payment of 1.25 billion USD, with the total potential value of the deal reaching 6.05 billion USD (approximately 43 billion yuan).
这项交易为三生制药带来了12.5亿美元的首付款，总潜在金额可达到60.5亿美元（约430亿元人民币）。This deal sets a record for the highest upfront payment ever received for a Chinese innovative drug, reflecting the rapid rise of Chinese pharmaceutical companies.
此次交易创下了国产创新药最高首付款的纪录，反映了中国在创新药领域的快速崛起。Experts note that Chinese pharmaceutical companies with core technologies and strong clinical data are increasingly competitive in the international market.
专家指出，中国拥有核心技术和优质临床数据的创新药物正日益增强其国际市场的竞争力。Despite complex Sino-US trade relations, cooperation between the two nations in the field of innovative pharmaceuticals remains vibrant.
尽管中美贸易关系复杂，双方在创新药领域的合作仍充满活力，展现了中国企业在全球医药市场的崭新面貌。
